Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Günter Henze

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Infant

Procedures

Phenomena

Recurrence

Chemicals & Drugs

Concepts & Ideas

Anatomy

Bone Marrow

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
45
Seeger, Karl
33
Riehm, Hansjörg
24
Schrappe, Martin
21
von Stackelberg, Arend
20
Taube, Tillmann
20
Reiter, Alfred
16
Eckert, Cornelia
15
Gadner, Helmut
13
Ludwig, Wolf-Dieter
11
Janka-Schaub, Gritta
11
Borgmann, Anja
11
Seifert, Georg
11
Zimmermann, Martin
10
Creutzig, Ursula
9
Kornhuber, Bernhard

Sign-in to see all Coauthors

Publications

TOP 3
Furth Christian; Steffen Ingo G; Amthauer Holger; Ruf Juri; Misch Daniel; Schönberger Stefan; Kobe Carsten; Denecke Timm; Stöver Brigitte; Hautzel Hubertus; Henze Günter; Hundsdoerfer Patrick
Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.
Hundsdoerfer Patrick; Albrecht Marion; Rühl Ursula; Fengler Rüdiger; Kulozik Andreas E; Henze Günter
Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
Rueckriegel Stefan Mark; Blankenburg Friederike; Henze Günter; Baqué Herrmann; Driever Pablo Hernáiz
Loss of fine motor function correlates with ataxia and decline of cognition in cerebellar tumor survivors.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Günter Henze (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Furth Christian; Steffen Ingo G; Amthauer Holger; Ruf Juri; Misch Daniel; Schönberger Stefan; Kobe Carsten; Denecke Timm; Stöver Brigitte; Hautzel Hubertus; Henze Günter; Hundsdoerfer Patrick
Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4385-91.
2009: Hundsdoerfer Patrick; Albrecht Marion; Rühl Ursula; Fengler Rüdiger; Kulozik Andreas E; Henze Günter
Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
European journal of cancer (Oxford, England : 1990) 2009;45(14):2447-51.
2009: Rueckriegel Stefan Mark; Blankenburg Friederike; Henze Günter; Baqué Herrmann; Driever Pablo Hernáiz
Loss of fine motor function correlates with ataxia and decline of cognition in cerebellar tumor survivors.
Pediatric blood & cancer 2009;53(3):424-31.
2009: Lueth Maria; Wronski Lena; Giese Almut; Kirschner-Schwabe Renate; Pietsch Torsten; von Deimling Andreas; Henze Guenter; Kurtz Andreas; Driever Pablo Hernáiz
Somatic mitochondrial mutations in pilocytic astrocytoma.
Cancer genetics and cytogenetics 2009;192(1):30-5.
2009: Burkhardt Birgit; Reiter Alfred; Landmann Eva; Lang Peter; Lassay Lisa; Dickerhoff Roswitha; Lakomek Max; Henze Günter; von Stackelberg Arend
Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3363-9.
2009: Kawamata Norihiko; Ogawa Seishi; Seeger Karl; Kirschner-Schwabe Renate; Huynh Thien; Chen John; Megrabian Nairi; Harbott Jochen; Zimmermann Martin; Henze Günter; Schrappe Martin; Bartram Claus R; Koeffler H Phillip
Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia.
International journal of oncology 2009;34(6):1603-12.
2009: Seifert Georg; Driever Pablo Hernáiz; Pretzer Kim; Edelhäuser Friedrich; Bach Susanne; Laue Hans-Broder V; Längler Alfred; Musial-Bright Lindy; Henze Günter; Cysarz Dirk
Effects of complementary eurythmy therapy on heart rate variability.
Complementary therapies in medicine 2009;17(3):161-7.
2009: Jesse Patrick; Mottke Gritt; Eberle Jürgen; Seifert Georg; Henze Günter; Prokop Aram
Apoptosis-inducing activity of Helleborus niger in ALL and AML.
Pediatric blood & cancer 2009;52(4):464-9.
2009: Reismüller Bettina; Attarbaschi Andishe; Peters Christina; Dworzak Michael N; Pötschger Ulrike; Urban Christian; Fink Franz-Martin; Meister Bernhard; Schmitt Klaus; Dieckmann Karin; Henze Günter; Haas Oskar A; Gadner Helmut; Mann Georg;
Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
British journal of haematology 2009;144(4):559-70.
2008: Rueckriegel Stefan Mark; Blankenburg Friederike; Burghardt Roland; Ehrlich Stefan; Henze Günter; Mergl Roland; Hernáiz Driever Pablo
Influence of age and movement complexity on kinematic hand movement parameters in childhood and adolescence.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2008;26(7):655-63.
2008: Blankenburg Friederike; Scheer Ianina; Sarioglu Nanette; Henze Günter; Driever Pablo Hernáiz; Riebel Thomas
Spontaneous regression of a vascular tumor of the skull base--infantile hemangioendothelioma?
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2008;30(9):712-5.
2008: Henze Günter
Early postinduction intensification therapy is essential in childhood acute lymphoblastic leukemia.
Nature clinical practice. Oncology 2008;5(9):502-3.
2008: Misch Daniel; Steffen Ingo G; Schönberger Stefan; Voelker Thomas; Furth Christian; Stöver Brigitte; Hautzel Hubertus; Henze Günter; Amthauer Holger; Denecke Timm
Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.
European journal of nuclear medicine and molecular imaging 2008;35(9):1642-50.
2008: Köchling Joachim; Prada Javier; Bahrami Masoud; Stripecke Renata; Seeger Karl; Henze Günter; Wittig Burghardt; Schmidt Manuel
Anti-tumor effect of DNA-based vaccination and dSLIM immunomodulatory molecules in mice with Ph+ acute lymphoblastic leukaemia.
Vaccine 2008;26(36):4669-75.
2008: Seifert Georg; Jesse Patrick; Laengler Alfred; Reindl Tobias; Lüth Maria; Lobitz Stephan; Henze Günter; Prokop Aram; Lode Holger N
Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro.
Cancer letters 2008;264(2):218-28.
2008: Reinmuth S; Liebeskind A-K; Wickmann L; Bockelbrink A; Keil T; Henze G; Borgmann A
Having children after surviving cancer in childhood or adolescence - results of a Berlin survey.
Klinische Pädiatrie 2008;220(3):159-65.
2008: Möricke Anja; Reiter Alfred; Zimmermann Martin; Gadner Helmut; Stanulla Martin; Dördelmann Michael; Löning Lutz; Beier Rita; Ludwig Wolf-Dieter; Ratei Richard; Harbott Jochen; Boos Joachim; Mann Georg; Niggli Felix; Feldges Andreas; Henze Günter; Welte Karl; Beck Jörn-Dirk; Klingebiel Thomas; Niemeyer Charlotte; Zintl Felix; Bode Udo; Urban Christian; Wehinger Helmut; Niethammer Dietrich; Riehm Hansjörg; Schrappe Martin;
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood 2008;111(9):4477-89.
2008: von Stackelberg Arend; Hartmann Reinhard; Bührer Christoph; Fengler Rüdiger; Janka-Schaub Gritta; Reiter Alfred; Mann Georg; Schmiegelow Kjeld; Ratei Richard; Klingebiel Thomas; Ritter Jörg; Henze Günter;
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.
Blood 2008;111(5):2573-80.
2008: Borgmann Anja; Zinn Christina; Hartmann Reinhard; Herold Ralf; Kaatsch Peter; Escherich Gabriele; Möricke Anja; Henze Günter; von Stackelberg Arend;
Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
European journal of cancer (Oxford, England : 1990) 2008;44(2):257-68.
2007: Blankenburg Friederike; van Landeghem Frank K H; Plotkin Michail; Henze Günter; von Deimling Andreas; Driever Pablo Hernáiz
Occurrence of a spinal anaplastic pilocytic astrocytoma and a supratentorial PNET in an adolescent.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2007;29(12):832-5.
2007: Völker Thomas; Denecke Timm; Steffen Ingo; Misch Daniel; Schönberger Stefan; Plotkin Michail; Ruf Juri; Furth Christian; Stöver Brigitte; Hautzel Hubertus; Henze Günter; Amthauer Holger
Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5435-41.
2007: Hagedorn Nikola; Acquaviva Cécile; Fronkova Eva; von Stackelberg Arend; Barth Andrea; zur Stadt Udo; Schrauder André; Trka Jan; Gaspar Nathalie; Seeger Karl; Henze Günter; Cavé Hélène; Eckert Cornelia;
Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of "isolated" and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group.
Blood 2007;110(12):4022-9.
2007: Seifert Georg; Laengler Alfred; Tautz Christoph; Seeger Karl; Henze Günter
Response to subcutaneous therapy with mistletoe in recurrent multisystem Langerhans cell histiocytosis.
Pediatric blood & cancer 2007;48(5):591-2.
2007: Giese Almut; Kirschner-Schwabe Renate; Blumchen Katharina; Wronski Lena; Shalapour Shabnam; Prada Javier; Driever Pablo Hernáiz; Brauer Martin; Schuelke Markus; Henze Günter; Seeger Karl
Prenatal manifestation of pancytopenia in Pearson marrow-pancreas syndrome caused by a mitochondrial DNA deletion.
American journal of medical genetics. Part A 2007;143(3):285-8.
2007: Karachunskii A I; Miakova N V; Rumiantseva Iu V; Timakov A M; Makhortykh T Zh; Fechina L G; Shamardina A V; Dudkin S A; Lebedev V V; Varfolomeeva S R; Timofeeva V N; Herold R; Stakelberg A; Henze G; Rumiantsev A G
[The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91/ALL-BFM 90m in children: analysis of efficacy and toxicity]
Terapevticheskii arkhiv 2007;79(7):19-26.
2006: Seifert Georg; Kress Wolfram; Meisel Christian; Henze Günter; Seeger Karl
Genetic investigations of Saethre-Chotzen syndrome presenting with renal cell carcinoma.
Cancer genetics and cytogenetics 2006;171(1):76-8.
2006: Furth C; Amthauer H; Denecke T; Ruf J; Henze G; Gutberlet M
Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcoma.
Pediatric blood & cancer 2006;47(5):607-11.
2006: Shalapour Shabnam; Zelmer Andrea; Pfau Madlen; Moderegger Eva; Costa-Blechschmidt Cristiane; van Landeghem Frank K H; Taube Tillmann; Fichtner Iduna; Bührer Christoph; Henze Günter; Seeger Karl; Wellmann Sven
The thalidomide analogue, CC-4047, induces apoptosis signaling and growth arrest in childhood acute lymphoblastic leukemia cells in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5526-32.
2006: Furth Christian; Denecke Timm; Steffen Ingo; Ruf Juri; Voelker Thomas; Misch Daniel; Vondran Florian; Plotkin Michail; Stöver Brigitte; Henze Günter; Lemke Arne-Jörn; Amthauer Holger
Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2006;28(8):501-12.
2006: Kirschner-Schwabe Renate; Lottaz Claudio; Tödling Jörn; Rhein Peter; Karawajew Leonid; Eckert Cornelia; von Stackelberg Arend; Ungethüm Ute; Kostka Dennis; Kulozik Andreas E; Ludwig Wolf-Dieter; Henze Günter; Spang Rainer; Hagemeier Christian; Seeger Karl
Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4553-61.
2006: Einsiedel H Graf; Kawan L; Eckert C; Witt O; Fichtner I; Henze G; Seeger K
Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(8):1435-6.
2006: Seifert Georg; Reindl Tobias; Lobitz Stephan; Seeger Karl; Henze Guenter
Fatal course after administration of rituximab in a boy with relapsed all: a case report and review of literature.
Haematologica 2006;91(6 Suppl):ECR23.
2006: Wu Shuling; Gessner Reinhard; Taube Tillmann; Korte Alexander; von Stackelberg Arend; Kirchner Renate; Henze Guenter; Seeger Karl
Chemokine IL-8 and chemokine receptor CXCR3 and CXCR4 gene expression in childhood acute lymphoblastic leukemia at first relapse.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2006;28(4):216-20.
2006: Taube Tillmann; von Stackelberg Arend; Schulte-Overberg Ursula; Henze Günter; Schmid Hansjörg; Reinhard Harald
Chronic immune thrombocytopentic purpura in children: assessment of rituximab treatment.
The Journal of pediatrics 2006;148(3):423.
2006: Claviez Alexander; Eckert Cornelia; Seeger Karl; Schrauder André; Schrappe Martin; Henze Günter; von Stackelberg Arend
Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.
Haematologica 2006;91(2):272-3.
2006: Reindl Tobias K; Geilen Wilhelm; Hartmann Reinhard; Wiebelitz Klaus R; Kan Guishi; Wilhelm Ilca; Lugauer Siegfried; Behrens Clemens; Weiberlenn Thomas; Hasan Carola; Gottschling Sven; Wild-Bergner Tanja; Henze Guenter; Driever Pablo Hernáiz
Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(2):172-6.
2006: Burkhardt Birgit; Woessmann Wilhelm; Zimmermann Martin; Kontny Udo; Vormoor Josef; Doerffel Wolfgang; Mann Georg; Henze Guenter; Niggli Felix; Ludwig Wolf-Dieter; Janssen Dirk; Riehm Hansjoerg; Schrappe Martin; Reiter Alfred
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):491-9.
2006: Seifert G; Seeger K; Reindl T; Voelker T; Henze G
A metastatic alveolar rhabdomyosarcoma of the hand.
Pediatric blood & cancer 2006;46(1):115-6.
2006: Seifert Georg; Taube Tillmann; Paal Kriztina; von Einsiedel Hagen Graf; Wellmann Sven; Henze Günter; Seeger Karl; Schroff Matthias; Wittig Burghardt
Brief communication: stability and catalytic activity of novel circular DNAzymes.
Nucleosides, nucleotides & nucleic acids 2006;25(7):785-93.
2006: Seifert Georg; Riess Hanno; Seeger Karl; Henze Guenter; Borgmann Anja
Intraluminal instillation of urokinase and autologous plasma: a method to unblock occluded central venous ports.
BMC cancer 2006;6():103.
2005: Creutzig U; Zimmermann M; Ritter J; Reinhardt D; Hermann J; Henze G; Jürgens H; Kabisch H; Reiter A; Riehm H; Gadner H; Schellong G
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(12):2030-42.
2005: Amthauer H; Furth C; Denecke T; Hundsdoerfer P; Voelker T; Seeger K; Stöver B; Henze G
FDG-PET in 10 children with non-Hodgkin's lymphoma: initial experience in staging and follow-up.
Klinische Pädiatrie 2005;217(6):327-33.
2005: Einsiedel Hagen Graf; von Stackelberg Arend; Hartmann Reinhard; Fengler Rüdiger; Schrappe Martin; Janka-Schaub Gritta; Mann Georg; Hählen Karel; Göbel Ulrich; Klingebiel Thomas; Ludwig Wolf-Dieter; Henze Günter
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7942-50.
2005: Friedrich Carsten; Holtkamp Nikola; Cinatl Jindrich; Sakuma Sadatoshi; Mautner Victor F; Wellman Sven; Michaelis Martin; Henze Günter; Kurtz Andreas; Driever Pablo Hernáiz
Overexpression of Midkine in malignant peripheral nerve sheath tumor cells inhibits apoptosis and increases angiogenic potency.
International journal of oncology 2005;27(5):1433-40.
2005: Berthold Frank; Boos Joachim; Burdach Stefan; Erttmann Rudolf; Henze Günter; Hermann Johann; Klingebiel Thomas; Kremens Bernhard; Schilling Freimut H; Schrappe Martin; Simon Thorsten; Hero Barbara
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.
The lancet oncology 2005;6(9):649-58.
2005: Nenning Uta C F; Eckert Cornelia; Wellmann Sven; Barth Andrea; Henze Günter; Seeger Karl
Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Journal of the National Cancer Institute 2005;97(14):1091-2; author reply 1093-5.
2005: Creutzig Ursula; Zimmermann Martin; Hannemann Julia; Krämer Irene; Pfistner Beate; Herold Ralf; Henze Günter
Quality management for clinical trials within the German Competence Network Paediatric Oncology and Haematology.
Onkologie 2005;28(6-7):333-6.
2005: Kaspers Gertjan J L; Wijnands Jelle J M; Hartmann Reinhard; Huismans Loekie; Loonen Anne H; Stackelberg Arend; Henze Guenter; Pieters Robrecht; Hählen Karel; Van Wering Elisabeth R; Veerman Anjo J P
Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
European journal of cancer (Oxford, England : 1990) 2005;41(9):1300-3.
2005: Wu Shuling; Gessner Reinhard; Taube Tillmann; von Stackelberg Arend; Henze Günter; Seeger Karl
Expression of interleukin-10 splicing variants is a positive prognostic feature in relapsed childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):3038-42.
2005: Wellmann S; Moderegger E; Zelmer A; Bettkober M; von Stackelberg A; Henze G; Seeger K
FLT3 mutations in childhood acute lymphoblastic leukemia at first relapse.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(3):467-8.
2005: Wu Shuling; Gessner Reinhard; von Stackelberg Arend; Kirchner Renate; Henze Guenter; Seeger Karl
Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
Cancer 2005;103(5):1054-63.
2005: Buchen S; Ngampolo D; Melton R G; Hasan C; Zoubek A; Henze G; Bode U; Fleischhack G
Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.
British journal of cancer 2005;92(3):480-7.
2005: Wu Shuling; Korte Alexander; Kebelmann-Betzing Christian; Gessner Reinhard; Henze Guenter; Seeger Karl
Interaction of bone marrow stromal cells with lymphoblasts and effects of predinsolone on cytokine expression.
Leukemia research 2005;29(1):63-72.
2004: Creutzig U; Jürgens H; Herold R; Göbel U; Henze G
[Concepts of the Society of Paediatric Oncology and Haematology (GPOH) and the German Competence Network in Paediatric Oncology and Haematology for the quality controlled development in paediatric oncology]
Klinische Pädiatrie 2004;216(6):379-83.
2004: von Stackelberg A; Seeger K; Henze G; Eckert C
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(10):1727-8; author reply 1728-9.
2004: Eckert Cornelia; Einsiedel Hagen Graf; Hartmann Reinhard; von Stackelberg Arend; Völpel Sigrid; Guggemos Andreas; Hanzsch Nikola; Kawan Lars; Seeger Karl; Henze Günter
Clonal stability of initial leukemia in a child with central nervous system relapse 7.4 years after bone marrow relapse of common acute lymphoblastic leukemic.
Haematologica 2004;89(7):ECR23.
2004: Taube Tillmann; Eckert Cornelia; Körner Gabriele; Henze Günter; Seeger Karlheinz
Real-time quantification of TEL-AML1 fusion transcripts for MRD detection in relapsed childhood acute lymphoblastic leukaemia. Comparison with antigen receptor-based MRD quantification methods.
Leukemia research 2004;28(7):699-706.
2004: Bader Peter; Kreyenberg Hermann; Hoelle Walter; Dueckers Gregor; Handgretinger Rupert; Lang Peter; Kremens Bernhard; Dilloo Dagmar; Sykora Karl-Walter; Schrappe Martin; Niemeyer Charlotte; Von Stackelberg Arend; Gruhn Bernd; Henze Günter; Greil Johann; Niethammer Dietrich; Dietz Klaus; Beck James F; Klingebiel Thomas
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1696-705.
2004: Wellmann S; Guschmann M; Griethe W; Eckert C; von Stackelberg A; Lottaz C; Moderegger E; Einsiedel H G; Eckardt K-U; Henze G; Seeger K;
Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(5):926-33.
2004: Tallen Gesche; Kaiser Ines; Krabbe Sonja; Lass Ulrike; Hartmann Christian; Henze Günter; Riabowol Karl; von Deimling Andreas
No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma.
International journal of cancer. Journal international du cancer 2004;109(3):476-9.
2003: Prokop Aram; Wrasidlo Wolf; Lode Holger; Herold Ralf; Lang Florian; Henze Günter; Dörken Bernd; Wieder Thomas; Daniel Peter T
Induction of apoptosis by enediyne antibiotic calicheamicin thetaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner.
Oncogene 2003;22(57):9107-20.
2003: Creutzig U; Zimmermann M; Hannemann J; Krämer I; Herold R; Henze G
[Quality management within the competence network of paediatric oncology and haematology]
Klinische Pädiatrie 2003;215(6):338-40.
2003: Köchling Joachim; König-Merediz Sven A; Stripecke Renata; Buchwald Dirk; Korte Alexander; Von Einsiedel Hagen G; Sack Florian; Henze Günter; Seeger Karl; Wittig Burghardt; Schmidt Manuel
Protection of mice against Philadelphia chromosome-positive acute lymphoblastic leukemia by cell-based vaccination using nonviral, minimalistic expression vectors and immunomodulatory oligonucleotides.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):3142-9.
2003: Wu Shuling; Korte Alexander; Gessner Reinhard; Henze Guenter; Seeger Karlheinz
Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
Cancer 2003;98(3):625-31.
2003: Berthold F; Hero B; Kremens B; Handgretinger R; Henze G; Schilling F H; Schrappe M; Simon T; Spix C
Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age.
Cancer letters 2003;197(1-2):11-7.
2003: Guggemos Andreas; Eckert Cornelia; Szczepanski Tomasz; Hanel Claudia; Taube Tillmann; van der Velden Vincent H J; Graf-Einsiedel Hagen; Henze Günter; Seeger Karlheinz
Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia.
Haematologica 2003;88(7):737-46.
2003: Fichtner Iduna; Paal Krisztina; Borgmann Anja; Badiali Lucia; Wurm Reinhard; Henze Günter
Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias--correlation to the expression of multidrug resistance proteins.
Anticancer research 2003;23(3B):2657-64.
2003: Borgmann Anja; von Stackelberg Arend; Hartmann Reinhard; Ebell Wolfram; Klingebiel Thomas; Peters Christina; Henze Gunter;
Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis.
Blood 2003;101(10):3835-9.
2003: Kaaijk P; Kaspers G J L; Van Wering E R; Broekema G J; Loonen A H; Hählen K; Schmiegelow K; Janka-Schaub G E; Henze G; Creutzig U; Veerman A J P
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.
British journal of cancer 2003;88(5):775-81.
2002: Graf Einsiedel Hagen; Taube Tillmann; Hartmann Reinhard; Wellmann Sven; Seifert Georg; Henze Günter; Seeger Karl
Deletion analysis of p16(INKa) and p15(INKb) in relapsed childhood acute lymphoblastic leukemia.
Blood 2002;99(12):4629-31.
2002: Müller Hans-Joachim; Beier Rita; da Palma João Casimiro; Lanvers Claudia; Ahlke Elvira; von Schütz Volker; Gunkel Martin; Horn Alexander; Schrappe Martin; Henze Günter; Kranz Karen; Boos Joachim
PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols.
Cancer chemotherapy and pharmacology 2002;49(2):149-54.
2001: Kebelmann-Betzing C; Seeger K; Wolf R; Henze G
Traumatic lumbar puncture at diagnosis and outcome in childhood acute lymphoblastic leukemia.
Blood 2001;98(12):3496-7.
2001: Paulussen M; Ahrens S; Lehnert M; Taeger D; Hense H W; Wagner A; Dunst J; Harms D; Reiter A; Henze G; Niemeyer C; Göbel U; Kremens B; Fölsch U R; Aulitzky W E; Voûte P A; Zoubek A; Jürgens H
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(11):1619-30.
2001: Wieder T; Prokop A; Bagci B; Essmann F; Bernicke D; Schulze-Osthoff K; Dörken B; Schmalz H G; Daniel P T; Henze G
Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(11):1735-42.
2001: Seeger K; von Stackelberg A; Taube T; Buchwald D; Körner G; Suttorp M; Dörffel W; Tausch W; Henze G
Relapse of TEL-AML1--positive acute lymphoblastic leukemia in childhood: a matched-pair analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(13):3188-93.
2001: Graf Einsiedel H; Taube T; Hartmann R; Eckert C; Seifert G; Wellmann S; Henze G; Seeger K
Prognostic value of p16(INK4a) gene deletions in pediatric acute lymphoblastic leukemia.
Blood 2001;97(12):4002-4.
2001: Seeger K; Taube T; Eckert C; Hanel C; Pogodda M; Henze G
Unusual T-cell receptor-delta gene rearrangement patterns revealed by screening of a large series of childhood acute lymphoblastic leukaemia by multiplex polymerase chain reaction.
British journal of haematology 2001;113(2):318-22.
2001: Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2705-13.
2001: Vieira Pinheiro J P; Müller H J; Schwabe D; Gunkel M; Casimiro da Palma J; Henze G; von Schütz V; Winkelhorst M; Würthwein G; Boos J
Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia.
British journal of haematology 2001;113(1):115-9.
2001: Wellmann S; Taube T; Paal K; Graf V Einsiedel H; Geilen W; Seifert G; Eckert C; Henze G; Seeger K
Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology.
Clinical chemistry 2001;47(4):654-60.
2001: Seeger K; Kreuzer K A; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt C A; Henze G
Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
Cancer research 2001;61(6):2517-22.
2001: Seeger K; Viehmann S; Buchwald D; Harbott J; Schrappe M; Stary J; Henze G; Trka J
Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(2):280-2.
2001: Einsiedel H G; Taube T; Beyermann B; Dragon S; Möricke A; Kebelmann-Betzig C; Köchling J; Henze G; Seeger K
Absence of mutations in the CDKN2 binding site of CDK4 in childhood acute lymphoblastic leukemia.
Leukemia & lymphoma 2001;40(3-4):413-7.
2001: Kebelmann-Betzing C; Körner G; Badiali L; Buchwald D; Möricke A; Korte A; Köchling J; Wu S; Kappelmeier D; Oettel K; Henze G; Seeger K
Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor all.
Cytokine 2001;13(1):39-50.
2000: Schrappe M; Reiter A; Zimmermann M; Harbott J; Ludwig W D; Henze G; Gadner H; Odenwald E; Riehm H
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2205-22.
2000: Borgmann A; Baldy C; von Stackelberg A; Beyermann B; Fichtner I; Nürnberg P; Henze G
Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice.
Pediatric hematology and oncology 2000;17(8):635-50.
2000: Reich S; Bührer C; Henze G; Ohlendorf D; Mesche M; Sinha P; Kage A; Müller C; Vetter B; Kulozik A E
Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia.
Blood 2000;96(10):3357-63.
2000: Korte A; Köchling J; Badiali L; Eckert C; Andreae J; Geilen W; Kebelmann-Betzing C; Taube T; Wu S; Henze G; Seeger K
Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.
Cytokine 2000;12(11):1597-608.
2000: Prokop A; Wieder T; Sturm I; Essmann F; Seeger K; Wuchter C; Ludwig W D; Henze G; Dörken B; Daniel P T
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(9):1606-13.
2000: Müller H J; Löning L; Horn A; Schwabe D; Gunkel M; Schrappe M; von Schütz V; Henze G; Casimiro da Palma J; Ritter J; Pinheiro J P; Winkelhorst M; Boos J
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols.
British journal of haematology 2000;110(2):379-84.
2000: Rots M G; Pieters R; Peters G J; Noordhuis P; Van Zantwijk C H; Henze G; Janka-Schaub G E; Veerman A J; Jansen G
Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia.
British journal of haematology 2000;109(3):629-34.
2000: Schrappe M; Reiter A; Ludwig W D; Harbott J; Zimmermann M; Hiddemann W; Niemeyer C; Henze G; Feldges A; Zintl F; Kornhuber B; Ritter J; Welte K; Gadner H; Riehm H
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.
Blood 2000;95(11):3310-22.
2000: Löning L; Zimmermann M; Reiter A; Kaatsch P; Henze G; Riehm H; Schrappe M
Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy.
Blood 2000;95(9):2770-5.
2000: Eckert C; Landt O; Taube T; Seeger K; Beyermann B; Proba J; Henze G
Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(2):316-23.
2000: Reiter A; Schrappe M; Ludwig W D; Tiemann M; Parwaresch R; Zimmermann M; Schirg E; Henze G; Schellong G; Gadner H; Riehm H
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.
Blood 2000;95(2):416-21.
1999: Den Boer M L; Pieters R; Kazemier K M; Janka-Schaub G E; Henze G; Veerman A J
Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(12):2023-30.
1999: Reiter A; Schrappe M; Tiemann M; Ludwig W D; Yakisan E; Zimmermann M; Mann G; Chott A; Ebell W; Klingebiel T; Graf N; Kremens B; Müller-Weihrich S; Plüss H J; Zintl F; Henze G; Riehm H
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Blood 1999;94(10):3294-306.
1999: von Stackelberg A; Karatchunsky A; Kudrjashova J; Miakova N; Belikova L; Rumiantzev A; Hartmann R; Henze G
Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia: BFM 90m and MB 91.
European journal of cancer (Oxford, England : 1990) 1999;35(9):1349-55.
1999: Seeger K; Buchwald D; Taube T; Peter A; von Stackelberg A; Schmitt G; Köchling J; Henze G
TEL-AML1 positivity in relapsed B cell precursor acute lymphoblastic leukemia in childhood. Berlin-Frankfurt-Münster Study Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(9):1469-70.
1999: Seeger K; Buchwald D; Peter A; Taube T; von Stackelberg A; Schmitt G; Henze G
TEL-AML1 fusion in relapsed childhood acute lymphoblastic leukemia.
Blood 1999;94(1):374-6.
1999: Korte A; Möricke A; Beyermann B; Köchling J; Taube T; Kebelmann-Betzing C; Henze G; Seeger K
Extensive alternative splicing of interleukin-7 in malignant hematopoietic cells: implication of distinct isoforms in modulating IL-7 activity.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(5):495-503.
1999: Reich S; Overberg-Schmidt U S; Leenen A; Henze G
Neurofibromatosis 1 associated with embryonal rhabdomyosarcoma of the urinary bladder.
Pediatric hematology and oncology 1999;16(3):263-6.
1999: Creutzig U; Zimmermann M; Ritter J; Henze G; Graf N; Löffler H; Schellong G
Definition of a standard-risk group in children with AML.
British journal of haematology 1999;104(3):630-9.
1999: Den Boer M L; Pieters R; Kazemier K M; Janka-Schaub G E; Henze G; Creutzig U; Kaspers G J; Kearns P R; Hall A G; Pearson A D; Veerman A J
Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia.
British journal of haematology 1999;104(2):321-7.
1998: Dördelmann M; Reiter A; Zimmermann M; Fengler R; Henze G; Riehm H; Schrappe M
Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1998;20(5):444-50.
1998: Dörffel W; Albrecht M; Lüders H; Marciniak H; Parwaresch R; Schwarze E W; Trauzeddel R; Havers W; Henze G; Janka-Schaub G; Mann G; Niemeyer C; Pötter R; Schellong G; Selle B; Treuner J; Rühl U
[Multi-national therapy study for Hodgkin's disease in children and adolescents GPOH-DH 95. Interim report after 2 1/2 years]
Klinische Pädiatrie 1998;210(4):212-9.
1998: Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Klinische Pädiatrie 1998;210(4):192-9.
1998: den Boer M L; Pieters R; Kazemier K M; Janka-Schaub G E; Henze G; Veerman A J
The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(6):912-20.
1998: Borgmann A; von Stackelberg A; Baumgarten E; Uchanska-Ziegler B; Ziegler A; Wittig B; Henze G
Immunotherapy of acute lymphoblastic leukemia by vaccination with autologous leukemic cells transfected with a cDNA expression plasmid coding for an allogeneic HLA class I antigen combined with interleukin-2 treatment.
Journal of molecular medicine (Berlin, Germany) 1998;76(3-4):215-21.
1998: den Boer M L; Pieters R; Kazemier K M; Rottier M M; Zwaan C M; Kaspers G J; Janka-Schaub G; Henze G; Creutzig U; Scheper R J; Veerman A J
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
Blood 1998;91(6):2092-8.
1998: Seeger K; Adams H P; Buchwald D; Beyermann B; Kremens B; Niemeyer C; Ritter J; Schwabe D; Harms D; Schrappe M; Henze G
TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
Blood 1998;91(5):1716-22.
1997: Borgmann A; Baumgarten E; Schmid H; Dopfer R; Ebell W; Göbel U; Niethammer D; Gadner H; Henze G
Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?
Bone marrow transplantation 1997;20(11):939-44.
1997: Harbott J; Viehmann S; Borkhardt A; Henze G; Lampert F
Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse.
Blood 1997;90(12):4933-7.
1997: Taube T; Seeger K; Beyermann B; Hanel C; Duda S; Linderkamp C; Henze G
Multiplex PCR for simultaneous detection of the most frequent T cell receptor-delta gene rearrangements in childhood ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(11):1978-82.
1997: Beyermann B; Adams H P; Henze G
Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia: a matched-pair analysis. Berlin-Frankfurt-Münster Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2231-7.
1997: Neuendank A; Hartmann R; Bührer C; Winterhalter B; Klumper E; Veerman A J; Henze G
Acute toxicity and effectiveness of idarubicin in childhood acute lymphoblastic leukemia.
European journal of haematology 1997;58(5):326-32.
1997: Kleinau I; Perez-Canto A; Schmid H J; Grassot A; Staab D; Renz H; Henze G; Wahn U; Paul K
Bronchiolitis obliterans organizing pneumonia and chronic graft-versus-host disease in a child after allogeneic bone marrow transplantation.
Bone marrow transplantation 1997;19(8):841-4.
1996: Schmid H; von Schenck U; Hartmann R; Borgmann A; Henze G
Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: results of BFM ALL relapse studies. BFM Relapse Study Group.
Bone marrow transplantation 1996;18 Suppl 2():28-30.
1996: Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2812-7.
1996: Bührer C; Herold R; Stibenz D; Henze G; Obladen M
Cerebrospinal fluid soluble L-selectin (sCD62L) in meningoencephalitis.
Archives of disease in childhood 1996;74(4):288-92.
1996: Beyermann B; Agthe A G; Adams H P; Seeger K; Linderkamp C; Goetze G; Ludwig W D; Henze G
Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. BFM Relapse Study Group.
Blood 1996;87(4):1532-8.
1995: Emeis M; Liesenfeld O; Henze G; Meredith S; Schoone G; Stück B
[Imported visceral leishmaniasis (kala azar) in a German infant]
Klinische Pädiatrie 1995;207(6):347-9.
1995: Borgmann A; Schmid H; Hartmann R; Baumgarten E; Hermann K; Klingebiel T; Ebell W; Zintl F; Gadner H; Henze G
Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.
Lancet 1995;346(8979):873-6.
1995: Rodriguez T; Baumgarten E; Fengler R; Soumpasis D; Henze G
[Long-term infusion of L-asparaginase--an alternative to intramuscular injection?]
Klinische Pädiatrie 1995;207(4):207-10.
1995: Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
Bone marrow transplantation 1995;15(4):515-21.
1995: Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora K W; Ludwig W D; Gadner H; Riehm H
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):359-72.
1994: Reiter A; Schrappe M; Ludwig W D; Hiddemann W; Sauter S; Henze G; Zimmermann M; Lampert F; Havers W; Niethammer D
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.
Blood 1994;84(9):3122-33.
1994: Belz S; Frickel C; Wolfrom C; Nau H; Henze G
High-performance liquid chromatographic determination of methotrexate, 7-hydroxymethotrexate, 5-methyltetrahydrofolic acid and folinic acid in serum and cerebrospinal fluid.
Journal of chromatography. B, Biomedical applications 1994;661(1):109-18.
1994: Lawrenz-Wolf B; Wolfrom C; Frickel C; Fengler R; Wehinger H; Henze G
[Severe renal impairment of methotrexate elimination after high dose therapy]
Klinische Pädiatrie 1994;206(4):319-26.
1994: Baumgarten E; Herbst H; Schmitt M; Seeger K H; Schulte-Overberg U; Henze G
Life-threatening infectious mononucleosis: is it correlated with virus-induced T cell proliferation?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(1):152-6.
1994: Bührer C; Hartmann R; Fengler R; Schober S; Arlt I; Loewke M; Henze G
Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin-Frankfurt-Münster) Relapse Study Group.
Blood 1994;83(12):3468-72.
1994: Schwella N; Schwerdtfeger R; König V; Blasczyk R; Schmid H; Schmidt-Wolf I; Henze G; Siegert W
Allogeneic bone marrow transplantation for recurrence of leukemia after autologous bone marrow transplantation.
Transplantation 1994;57(8):1263-5.
1994: Overberg-Schmidt U; Wegner R D; Baumgarten E; Günther A; Ebell W; Stein H; Vogel M; Henze G
Low-grade non-Hodgkin's lymphoma after high-grade non-Hodgkin's lymphoma in a child with ataxia telangiectasia.
Cancer 1994;73(5):1522-5.
1993: Schmid H; Henze G; Schwerdtfeger R; Baumgarten E; Besserer A; Scheffler A; Serke S; Zingsem J; Siegert W
Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia.
Bone marrow transplantation 1993;12(6):597-602.
1993: Baumgarten E; Wegner R D; Fengler R; Koch H; Henze G
Partial trisomy 1q, an uncommon chromosomal aberration in erythroleukemia.
Leukemia & lymphoma 1993;10(3):237-40.
1993: Bührer C; Luxenburger U; Metze B; Kattner E; Henze G; Dudenhausen J W; Obladen M
Diminished cord blood lymphocyte L-selectin expression in neonatal bacterial infection.
European journal of pediatrics 1993;152(6):519-22.
1993: Wolfrom C; Hartmann R; Fengler R; Brühmüller S; Ingwersen A; Henze G
Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(5):827-33.
1993: Bührer C; Hartmann R; Fengler R; Dopfer R; Gadner H; Gerein V; Göbel U; Reiter A; Ritter J; Henze G
Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia.
Medical and pediatric oncology 1993;21(7):470-6.
1992: Reiter A; Schrappe M; Ludwig W D; Lampert F; Harbott J; Henze G; Niemeyer C M; Gadner H; Müller-Weihrich S; Ritter J
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Blood 1992;80(10):2471-8.
1991: Henze G; Fengler R; Hartmann R; Kornhuber B; Janka-Schaub G; Niethammer D; Riehm H
Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.
Blood 1991;78(5):1166-72.
1991: Koch H; Schmitz L; Brockmeier K; Hartmann R; Bein G; Henze G
[Long-term study of anthracycline-induced cardiomyopathy in children and adolescents]
Klinische Pädiatrie 1991;203(4):262-7.
1991: Bührer C; Atzpodien J; Oz S; Henze G
Fosfomycin does not reduce cytostatic activity of cis-platinum against human osteosarcoma cell lines in vitro.
Pediatric hematology and oncology 1991;8(3):243-9.
1991: Schwerdtfeger R; Schmid H; Baurmann H; Kleiner S; Zeiler T; Henze G; Siegert W
VP16 and TBI as conditioning regimen for allogeneic BMT in patients with high risk and relapsed ALL and NHL.
Bone marrow transplantation 1991;7 Suppl 2():131.
1991: Domeyer C; Schulte-Overberg U; Boll I; Baumgarten E; Bührer C; Fengler R; Henze G
Erythroblastopenia in two patients after splenectomy and polychemotherapy.
The American journal of pediatric hematology/oncology 1991;13(3):320-5.
1990: Siegert W; Josimovic-Alasevic O; Schwerdtfeger R; Baurmann H; Schmidt C A; Musch R; Schmid H J; Hartmann R; Henze G; Huhn D
Soluble interleukin 2 receptors in patients after bone marrow transplantation.
Bone marrow transplantation 1990;6(2):97-101.
1990: Siegert W; Josimovic-Alasevic O; Schwerdtfeger R; Schmidt C; Neubauer A; Henze G; Huhn D; Diamantstein T
Determination of soluble interleukin-2 receptors after bone marrow transplantation.
Haematology and blood transfusion 1990;33():76-7.
1990: Baumgarten E; Fengler R; Brockmeier K; Domeyer C; Schulte-Overberg U; Schmid H J; Scheffner D; Henze G
Syndrome of the posterior and anterior root in a late isolated CNS relapse of c-ALL. Case report.
Neurosurgical review 1990;13(1):73-5.
1990: Niethammer D; Klingebiel T; Dopfer R; Ehninger G; Henze G; Schaefer W; Stollmann B; Ebell W; Link M; Riehm H
Allogeneic bone marrow transplantation in childhood leukemia: results and strategies in the Federal Republic of Germany.
Haematology and blood transfusion 1990;33():638-48.
1990: Henze G; Fengler R; Hartmann R; Niethammer D; Schellong G; Riehm H
BFM group treatment results in relapsed childhood acute lymphoblastic leukemia.
Haematology and blood transfusion 1990;33():619-26.
1990: Fengler R; Hartmann R; Bode U; Janka G; Jürgens H; Riehm H; Henze G
Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia.
Haematology and blood transfusion 1990;33():511-5.
1990: Bührer C; Henze G; Hofmann J; Reiter A; Schellong G; Riehm H
Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials.
Haematology and blood transfusion 1990;33():500-3.
1990: Henze G; Fengler R; Reiter A; Ritter J; Riehm H
Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia.
Haematology and blood transfusion 1990;33():483-8.
1990: Riehm H; Gadner H; Henze G; Kornhuber B; Lampert F; Niethammer D; Reiter A; Schellong G
Results and significance of six randomized trials in four consecutive ALL-BFM studies.
Haematology and blood transfusion 1990;33():439-50.
1990: Wolfrom C; Hepp R; Hartmann R; Breithaupt H; Henze G
Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
European journal of clinical pharmacology 1990;39(4):377-83.
1989: Henze G; Fengler R; Hartmann R; Dopfer R; Göbel U; Graf N; Jürgens H; Niethammer D; Ritter J; Schellong G
Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia.
Cancer chemotherapy and pharmacology 1989;24 Suppl 1():S16-9.
1989: Baumgarten E; Wegner R D; Fengler R; Ludwig W D; Schulte-Overberg U; Domeyer C; Schüürmann J; Henze G
Calla-positive acute leukaemia with t(5q;14q) translocation and hypereosinophilia--a unique entity?
Acta haematologica 1989;82(2):85-90.
1988: Berthold F; Bender-Götze C; Dopfer R; Erttmann R; Haas R J; Henze G; Körbling M; Riehm H; Rister M; Stollmann B
[Myeloablative chemo- and radiotherapy with autologous and allogenic bone marrow reconstitution in children with metastatic neuroblastoma]
Klinische Pädiatrie 1988;200(3):221-5.
1987: Riehm H; Reiter A; Schrappe M; Berthold F; Dopfer R; Gerein V; Ludwig R; Ritter J; Stollmann B; Henze G
[Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]
Klinische Pädiatrie 1987;199(3):151-60.
1987: Schrappe M; Beck J; Brandeis W E; Feickert H J; Gadner H; Graf N; Havers W; Henze G; Jobke A; Kornhuber B
[Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81]
Klinische Pädiatrie 1987;199(3):133-50.
1987: Henze G; Buchmann S; Fengler R; Hartmann R
The BFM relapse studies in childhood ALL: concepts of two multicenter trials and results after 2 1/2 years.
Haematology and blood transfusion 1987;30():147-55.
1986: Baumgarten E; Buchmann S; Fengler R; Grosch-Wörner I; Schulte-Overberg U; Henze G
[Successful chemotherapy in a primary cerebral centroblastic non-Hodgkin's lymphoma in childhood]
Onkologie 1986;9(6):290-4.
1986: Fengler R; Pankrath K; Baumgarten E; Beck C; Becker H; Buchmann S; Grosch-Wörner I; Nessler G; Schuppert W; Henze G
[Malignant melanoma in the child--2 case reports]
Klinische Pädiatrie 1986;198(3):245-9.
1986: Creutzig U; Ritter J; Budde M; Riehm H; Henze G; Lampert F; Gerein V; Müller-Weihrich S; Niethammer D; Spaar H J
[Current results of cooperative AML therapy studies in children: BFM-78 and 83]
Klinische Pädiatrie 1986;198(3):183-90.
1986: Fengler R; Baumgarten E; Buchmann S; Creutzig U; Harbott J; Ludwig R; Henze G
[Biclonal leukemia O-ALL/AMoL) with 11;19 translocation and trisomy X in an 8-month-old girl]
Klinische Pädiatrie 1986;198(3):178-82.
1986: Henze G; Fengler R; Buchmann S
[Initial results of a study of the treatment of children with ALL recurrences]
Onkologie 1986;9(2):92-5.
1985: Creutzig U; Ritter J; Riehm H; Langermann H J; Henze G; Kabisch H; Niethammer D; Jürgens H; Stollmann B; Lasson U
Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78.
Blood 1985;65(2):298-304.
1984: Harten G; Stephani U; Henze G; Langermann H J; Riehm H; Hanefeld F
Slight impairment of psychomotor skills in children after treatment of acute lymphoblastic leukemia.
European journal of pediatrics 1984;142(3):189-97.
1984: Müller-Weihrich S; Henze G; Langermann H J; Odenwald E; Riehm H
[Childhood B-cell lymphomas and leukemias. Improvement of prognosis by a therapy developed for B-neoplasms by the BFM study group]
Onkologie 1984;7(4):205-8.
1984: Müller-Weihrich S; Beck J; Henze G; Jobke A; Kornhuber B; Lampert F; Ludwig R; Prindull G; Schellong G; Spaar H J
[BFM study 1981/83 of the treatment of highly malignant non-Hodgkin's lymphoma in children: results of therapy stratified according to histologic immunological type and clinical stage]
Klinische Pädiatrie 1984;196(3):135-42.
1984: Lampert F; Henze G; Langermann H J; Schellong G; Gadner H; Riehm H J
Acute lymphoblastic leukemia: current status of therapy in children.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1984;93():159-81.
1983: Habermalz E; Habermalz H J; Stephani U; Henze G; Riehm H; Hanefeld F
Cranial computed tomography of 64 children in continuous complete remission of leukemia I: relations to therapy in modalities.
Neuropediatrics 1983;14(3):144-8.
1983: Henze G; Langermann H J; Brämswig J; Schellong G; Ludwig R; Riehm H
[Results of preventive management of the central nervous system in 275 children with acute lymphoblastic leukemia]
Klinische Pädiatrie 1983;195(3):168-75.
1983: Creutzig U; Ritter J; Langermann H J; Riehm H; Henze G; Niethammer D; Jürgens H; Stollmann B; Lasson U; Kabisch H; Wahlen W; Löffler H; Schellong G
[Acute myelogenous leukemia in children: results of the cooperative BFM-78 therapy study after 3 3/4 years]
Klinische Pädiatrie 1983;195(3):152-60.
1983: Henze G; Lampert F; Langermann H J; Schellong G; Riehm H J
Prognosis of acute lymphoblastic leukemia related to initial findings and treatment.
Progress in clinical and biological research 1983;132D():445-9.
1983: Winkler K; Beron G; Kotz R; Salzer-Kuntschik M; Beck J; Beck W; Brandeis W; Ebell W; Erttmann R; Göbel U; Havers W; Henze G; Hinderfield L; Höcker P; Jobke A; Jürgens H; Kabisch H; Landbeck G; Preusser P; Prindull G; Ramach W; Ritter J; Sekera J; Treuner J; Wüst G
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
Journal of cancer research and clinical oncology 1983;106 Suppl():1-7.
1982: Neidhardt M; Habermalz H J; Henze G; Langermann H J
[Medulloblastoma study of the German Society for Pediatric Oncology, a first report]
Klinische Pädiatrie 1982;194(4):257-61.
1982: Müller-Weihrich S; Henze G; Jobke A; Kornhuber B; Langermann H J; Lasson U; Ludwig R; Ritter J; Schellong G; Stollmann B; Treuner J; Riehm H
[BFM study 1975/81 for treatment of non-Hodgkin lymphoma of high malignancy in children and adolescents]
Klinische Pädiatrie 1982;194(4):219-25.
1982: Winkler K; Beron G; Schellong G; Stollmann B; Prindull G; Lasson U; Brandeis W; Henze G; Ritter J; Russe W; Stengel-Rutkowski L; Treuner J; Landbeck G
[Cooperative osteosarcoma study COSS-77: results after 4 years]
Klinische Pädiatrie 1982;194(4):251-6.
1982: Fengler R; Henze G; Langermann H J; Brämswig J; Jobke A; Kornhuber B; Ludwig R; Ritter J; Riehm H
[Frequency and therapy results of testicular relapse in childhood acute lymphoblastic leukemia]
Klinische Pädiatrie 1982;194(4):204-8.
1982: Henze G; Langermann H J; Fengler R; Brandeis M; Evers K G; Gadner H; Hinderfeld L; Jobke A; Kornhuber B; Lampert F; Lasson U; Ludwig R; Müller-Weihrich S; Neidhardt M; Nessler G; Niethammer D; Rister M; Ritter J; Schaaff A; Schellong G; Stollmann B; Treuner J; Wahlen W; Weinel P; Wehinger H; Riehm H
[Acute lymphoblastic leukemia therapy study BFM 79/81 in children and adolescents: intensified reinduction therapy for patients with different risk for relapse]
Klinische Pädiatrie 1982;194(4):195-203.
1981: Welte K; Ebener U; Hinderfeld L; Ritter J; Henze G; Kornhuber B
[Implications of terminal deoxynucleotidyl transferase activity in various forms of childhood leukemia (author's transl)]
Klinische Pädiatrie 1981;193(3):165-71.
1981: Henze G; Langermann H J; Brämswig J; Breu H; Gadner H; Schellong G; Welte K; Riehm H
[The BFM 76/79 acute lymphoblastic leukemia therapy study (author's transl)]
Klinische Pädiatrie 1981;193(3):145-54.
1981: Henze G; Langermann H J; Kaufmann U; Ludwig R; Schellong G; Stollmann B; Riehm H
Thymic involvement and initial white blood count in childhood acute lymphoblastic leukemia.
The American journal of pediatric hematology/oncology 1981;3(4):369-76.

Sign-in to see more